Literature DB >> 29427903

The gut microbiota as a novel regulator of cardiovascular function and disease.

Micah L Battson1, Dustin M Lee1, Tiffany L Weir1, Christopher L Gentile2.   

Abstract

The gut microbiome has emerged as a critical regulator of human physiology. Deleterious changes to the composition or number of gut bacteria, commonly referred to as gut dysbiosis, has been linked to the development and progression of numerous diet-related diseases, including cardiovascular disease (CVD). Most CVD risk factors, including aging, obesity, certain dietary patterns, and a sedentary lifestyle, have been shown to induce gut dysbiosis. Dysbiosis is associated with intestinal inflammation and reduced integrity of the gut barrier, which in turn increases circulating levels of bacterial structural components and microbial metabolites that may facilitate the development of CVD. The aim of the current review is to summarize the available data regarding the role of the gut microbiome in regulating CVD function and disease processes. Particular emphasis is placed on nutrition-related alterations in the microbiome, as well as the underlying cellular mechanisms by which the microbiome may alter CVD risk.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiovascular disease; Dysbiosis; Microbiome; Microbiota; Obesity

Mesh:

Substances:

Year:  2017        PMID: 29427903     DOI: 10.1016/j.jnutbio.2017.12.010

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  40 in total

Review 1.  The gut microbiome and heart failure: A better gut for a better heart.

Authors:  Maxime Branchereau; Rémy Burcelin; Christophe Heymes
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

2.  Microbial metabolite indole-3-propionic acid supplementation does not protect mice from the cardiometabolic consequences of a Western diet.

Authors:  Dustin M Lee; Kayl E Ecton; S Raj J Trikha; Scott D Wrigley; Keely N Thomas; Micah L Battson; Yuren Wei; Sarah A Johnson; Tiffany L Weir; Christopher L Gentile
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-05-18       Impact factor: 4.052

Review 3.  Gut Epithelial Metabolism as a Key Driver of Intestinal Dysbiosis Associated with Noncommunicable Diseases.

Authors:  Catherine D Shelton; Mariana X Byndloss
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

4.  Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity.

Authors:  Micah L Battson; Dustin M Lee; Lance C Li Puma; Kayl E Ecton; Keely N Thomas; Hallie P Febvre; Adam J Chicco; Tiffany L Weir; Christopher L Gentile
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-27       Impact factor: 4.733

5.  The effect of inulin and resistant maltodextrin on weight loss during energy restriction: a randomised, placebo-controlled, double-blinded intervention.

Authors:  Anne Lundby Hess; Alfonso Benítez-Páez; Trine Blædel; Lesli Hingstrup Larsen; Jose Ramón Iglesias; Carmen Madera; Yolanda Sanz; Thomas Meinert Larsen
Journal:  Eur J Nutr       Date:  2019-10-11       Impact factor: 5.614

6.  Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome.

Authors:  Lei Ji; Siliang Chen; Guangchao Gu; Jiawei Zhou; Wei Wang; Jinrui Ren; Jianqiang Wu; Dan Yang; Yuehong Zheng
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

Review 7.  Berry-Derived Polyphenols in Cardiovascular Pathologies: Mechanisms of Disease and the Role of Diet and Sex.

Authors:  Rami S Najjar; Casey G Turner; Brett J Wong; Rafaela G Feresin
Journal:  Nutrients       Date:  2021-01-27       Impact factor: 5.717

8.  Dietary protein source contributes to the risk of developing maternal syndrome in the Dahl salt-sensitive rat.

Authors:  John Henry Dasinger; Justine M Abais-Battad; John D Bukowy; Hayley Lund; Ammar J Alsheikh; Daniel J Fehrenbach; Jeylan Zemaj; David L Mattson
Journal:  Pregnancy Hypertens       Date:  2021-05-05       Impact factor: 2.494

Review 9.  Gut microbes in cardiovascular diseases and their potential therapeutic applications.

Authors:  Ling Jin; Xiaoming Shi; Jing Yang; Yangyu Zhao; Lixiang Xue; Li Xu; Jun Cai
Journal:  Protein Cell       Date:  2020-09-28       Impact factor: 14.870

Review 10.  The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society.

Authors:  Barbara Strasser; Maike Wolters; Christopher Weyh; Karsten Krüger; Andrea Ticinesi
Journal:  Nutrients       Date:  2021-06-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.